Evidence map›Paper›PMID 40282397›Full record

ReviewGenes2025

RON Receptor Signaling and the Tumor Microenvironment.

Emily Wachter, Levi H Fox, Zhixin Lu, Angelle D Jones, Nicholas D Casto, Susan E Waltz

Abstract readReview
In one paragraph

Review in Genes, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Emily WachterDepartment of Cancer Biology, University of Cincinnati College of Medicine, Cincinnati, OH 45267-0521, USA.
Levi H FoxDepartment of Cancer Biology, University of Cincinnati College of Medicine, Cincinnati, OH 45267-0521, USA.ORCID 0000-0002-2996-1150
Zhixin LuDepartment of Cancer Biology, University of Cincinnati College of Medicine, Cincinnati, OH 45267-0521, USA.ORCID 0000-0002-7900-0200
Angelle D JonesDepartment of Cancer Biology, University of Cincinnati College of Medicine, Cincinnati, OH 45267-0521, USA.ORCID 0000-0003-3828-1808
Nicholas D CastoDepartment of Cancer Biology, University of Cincinnati College of Medicine, Cincinnati, OH 45267-0521, USA.ORCID 0009-0003-1067-9950
Susan E WaltzDepartment of Cancer Biology, University of Cincinnati College of Medicine, Cincinnati, OH 45267-0521, USA.ORCID 0000-0003-3572-4642

Funding

Defining genetic and metabolic requirements of aggressive breast cancerR01CA239697 · NCI · UNIVERSITY OF CINCINNATI · PI WALTZ, SUSAN E, WELLS, SUSANNE I · 2020 to 2024
$2.4M
Training Program in Basic and Translational OncologyT32CA298951 · NCI · UNIVERSITY OF CINCINNATI · PI Vinita Takiar, Susan E Waltz · 2025 to 2026
$776k
BLRD VA I01 BX000803NCI NIH HHS R01 CA239697NCI NIH HHS T32 CA298951NIH HHS 1R01CA239697-05A1VA I01 BX000803
6 · The paper itself

Abstract

The immune microenvironment plays a critical role in tumor growth and development. Immune activation within the tumor microenvironment is dynamic and can be modulated by tumor intrinsic and extrinsic signaling. The RON receptor tyrosine kinase is canonically associated with growth signaling and wound healing, and this receptor is frequently overexpressed in a variety of cancers. Epithelial cells, macrophages, dendritic cells, and fibroblasts express RON, presenting an important axis by which RON overexpressing tumors influence the tumor microenvironment. This review synthesizes the existing literature on the roles of tumor cell-intrinsic and -extrinsic RON signaling, highlighting areas of interest and gaps in knowledge that show potential for future studies.

Indexed as

NeoplasmsReceptor Protein-Tyrosine KinasesSignal TransductionTumor MicroenvironmentAnimalsGene Expression Regulation, NeoplasticHumansReceptor Protein-Tyrosine KinasesRON proteincancerHGFLimmune microenvironmentinterferonsmacrophagesmetastasismouse modelsRONRTKtumor microenvironment

Identifiers

PMID40282397
PMCPMC12026484

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.